These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 7989608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N.
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [Abstract] [Full Text] [Related]

  • 7. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
    Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V.
    Circulation; 1995 Sep 15; 92(6):1565-9. PubMed ID: 7664441
    [Abstract] [Full Text] [Related]

  • 8. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 15; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 9. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.
    Galis ZS, Sukhova GK, Kranzhöfer R, Clark S, Libby P.
    Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):402-6. PubMed ID: 7831299
    [Abstract] [Full Text] [Related]

  • 10. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G.
    Int J Cancer; 1995 Aug 09; 62(4):407-13. PubMed ID: 7635566
    [Abstract] [Full Text] [Related]

  • 11. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.
    Nikkari ST, Geary RL, Hatsukami T, Ferguson M, Forough R, Alpers CE, Clowes AW.
    Am J Pathol; 1996 Mar 09; 148(3):777-83. PubMed ID: 8774133
    [Abstract] [Full Text] [Related]

  • 12. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB.
    Surg Oncol; 1995 Mar 09; 4(2):111-9. PubMed ID: 7551259
    [Abstract] [Full Text] [Related]

  • 13. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG.
    Circulation; 1998 May 05; 97(17):1708-15. PubMed ID: 9591765
    [Abstract] [Full Text] [Related]

  • 14. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP.
    Invasion Metastasis; 1992 May 05; 12(3-4):168-84. PubMed ID: 1284126
    [Abstract] [Full Text] [Related]

  • 15. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
    Nakagawa T, Kubota T, Kabuto M, Fujimoto N, Okada Y.
    J Neurooncol; 1996 Apr 05; 28(1):13-24. PubMed ID: 8740587
    [Abstract] [Full Text] [Related]

  • 16. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec 05; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun 05; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]

  • 19. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G.
    J Am Acad Dermatol; 2004 Oct 05; 51(4):526-33. PubMed ID: 15389186
    [Abstract] [Full Text] [Related]

  • 20. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Oct 05; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.